Pharma M&As: value creator or value destroyer?
Anil Khanna, Partner, Tai Pi Advisors analyses the trend of rising M&As in the pharma industry and examines its causes and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Meningococcal vaccines market set to approach $1.8 bn by 2025: GlobalData
The provision of a single vaccine that can protect the population against all prevalent serogroups is the most important…
Frost & Sullivan study identifies top ten technologies transforming health and wellness
Provides trends, insights, and technologies of focus for stakeholders in this segment and the emerging market needs that are…
BIRAC, BMGF and IKP collaborate for GCE-India programme, call for proposals
GCE-India to seek innovative solutions in drug delivery systems, diagnostics, and technology enabled service models and medical…
M&As ka Side Effects
Indian pharma companies have notched up some aggressive global buys recently but the sector's experience with cross border…
‘India market is very important to us’
The number of Indian companies investing in Ireland through IDA Ireland has doubled in the last three years, from 15 companies in…
PatientSafe India to address the challenge of drug counterfeiting
The conference, to be held on June 28, 2016 at Courtyard Marriott, Mumbai, will deliberate on creative ways to raise awareness and…
Govt allows FDI in pharma
It has been decided to permit up to 74 per cent FDI under automatic route in brownfield pharmaceuticals
With the objective of…
Betting big on M&As
Dr Reddy's Laboratories' June 11 announcement that it had entered into an agreement with Teva and Allergan to buy eight…
Zydus Healthcare buys 2 ANDAs from Teva
The estimated market size of the two ANDAs put together is nearly $200 million
Zydus Healthcare, a subsidiary of Cadila…